By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of Infectious Disease and HIV/AIDS Policy, U.S. Department of Health and Human Services
Technical assistance slide set helps educate substance use disorder treatment providers on their critical role in diagnosing and treating those with HCV and HIV.
By: Adm. Brett P. Giroir, M.D., Assistant Secretary for Health
Opioid and drug misuse has profound economic and health consequences on Americans, including a rise in certain infectious diseases throughout our nation.
By: Tammy R. Beckham, DVM, PhD, DVM, PhD, Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Many thoughtful recommendations came from a broad array of stakeholders during the recent HHS listening session held in Washington, D.C.. Request for Information accepting written comments through March 11, 2019.
By: Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
First Listening Session Held at USCA to hear from community members regarding updates to National HIV/AIDS Strategy and National Viral Hepatitis Action Plans
By: Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Dr. Richard Wolitski reports on the 2017 Synchronicity Conference, including a panel that focused on improving HIV, hepatitis C, and LGBT health outcomes.
By: Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Scientific meeting advances efforts to cure hepatitis C infection among PLWH in Ryan White Care Act Programs
